π Inverse Cramer Jan 29

Lockheed Martin has come down so much that it’s getting hard for me to dislike it. I think the administration is far more focus on a Palantir solution to procurement. I do not want to get in the way of the Palantir buzz saw because thatβs very close to Elon Musk.
-On Lockheed Martin ($LMT)
I donβt have a catalyst. I would wait for it to come down before I would pull the trigger.
-On ADMA Biologics ($ADMA)
We want this one. This is a company that has solution and it’s not expensive at all. I like it, and I think you should own it, and I think you should buy it.
-On Keysight ($KEYS)
as if you needed another reason to stop paying for a $9 coffee https://t.co/qLgQZaKG0e
— Inverse Cramer (@CramerTracker) January 29, 2025
That’s a wrap. As always, we’ll be following Cramer’s every move so you can do the opposite.
See you tomorrow,
-IC